Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Nextfin is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments.
AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this, there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits.
* NextFin is the new trading name of Business Agent Ltd
The solution
NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self-promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way, businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition, an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace.
NextFin is raising £500k at a pre-money valuation of £2M to: • Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals
Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recently published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market-leading aggregator and has first-mover advantage. It has the potential to exceed these valuations because it is the whole of the market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.
days to go:
Expired
investment:
£274,057
DMALINK aims to create a transparent and accessible currency market for banks, funds, and corporations. The company asserts that the Foreign Exchange (FX) market is the world's largest and most liquid financial market, recording an average daily trading volume of $6.6 Trillion but is fraught with imperfect price movements. DMALINK aims to address this situation. Its portal utilises big data and analytics solutions to enable users to make better trading decisions. It also offers users access to 63 currency pair combinations. DMALINK also points out that its clients have chosen its services over 316,000 times with the company witnessing an average deal size of $585,000 and earning revenue worth $3,140,000. The company has featured in Business Insider, Yahoo Finance, and FX Markets to name a few. DMALINK will use 60% of the investment on salaries for existing and new team members allowing global growth, 20% towards marketing and sales efforts, and 20% towards technology expansion.
days to go:
Expired
investment:
£425,903
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
days to go:
Expired
investment:
£676,500
Offering people the opportunity to experience boating through a boat charter marketplace via a mobile app. Borrow A Boat allows customers to book a peer-to-peer or commercial boat near them from anywhere in the world. Boats and watercrafts listed on the platform range from stand-up paddleboards to superyachts.
Borrow A Boat lists over 16,000 boats on their marketplace, including boats from private owners. The service is available in 60 countries, with the option of renting the same day.
days to go:
Expired
investment:
£1,496,600
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.
days to go:
Expired
investment:
£908,950
The first wholesaler to offer insurance products for B2B and B2C firms in the Sharing Economy. Inlet aims provide insurance for assets that have been peer-to-peer rented for the short term, or for the provision of services such as letting properties online, as these markets are not currently covered by traditional insurances.
Inlet generates revenue from commissions via insurance products at the point of sale and at policy renewal. Income in the form of interest payments is also earned from customers that choose to pay via direct debit on a monthly basis, as well as from fees applied to customers who wish to amend their policies.
days to go:
Expired
investment:
£256,514
